Rare diseases
Investigational molecules
Locations
Back to Spain1 657 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Evaluation of CIT-013 at two dose levels compared to placebo for treating moderate to severe Hidradenitis Suppurativa
SpainStudy of zoldonrasib in patients with RAS G12D mutation non-small cell lung cancer who have received previous treatment
SpainStudy of AMG 732 injection compared to placebo in patients with moderate to severe thyroid eye disease
SpainStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
SpainStudy of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor
SpainStudy of VRDN-001 compared to placebo to evaluate safety and effectiveness in adults with chronic thyroid eye disease
SpainStudy of BMN 351 given by intravenous infusion to evaluate safety and tolerability in patients with Duchenne Muscular Dystrophy
SpainStudy of rimegepant for preventing chronic migraine in adolescents aged 12 to 17 years
SpainStudy of Orticumab in Adults with Previous Heart Attack and High Coronary Inflammation Measured by CT Scan
SpainStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
SpainStudy of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer
SpainLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.
Studies aim to improve treatment outcomes for patients with complex metabolic conditions.
Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.
Research focuses on developing targeted treatments for various neurological conditions.
Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.
Studies aim to enhance vaccine efficacy and immune response across different age groups.
Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.
Focus on developing innovative approaches to improve cancer treatment outcomes.
Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.
Research aims to develop more effective treatments for chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
